Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, 38 Xueyuan Road, Beijing, 100191, China.
Key Laboratory of Molecular Cardiovascular Sciences (Peking University), Ministry of Education, Beijing, China.
BMC Med. 2019 Aug 30;17(1):160. doi: 10.1186/s12916-019-1401-y.
Randomised control trials and genetic analyses have demonstrated that vitamin D or 25-hydroxyvitamin D (25[OH]D) levels may not play a causal role in the development of cardiovascular disease. However, it is unclear if 25(OH)D is causally associated with cause-specific vascular disease and lipids. Therefore, we examined the causal association of 25(OH)D with myocardial infarction, stroke, ischaemic heart disease, ischaemic stroke, subarachnoid haemorrhage, intracerebral haemorrhage, and lipid levels among both Chinese and Europeans.
We used a Mendelian randomisation (MR) design in the China Kadoorie Biobank, the Copenhagen City Heart Study, and the Copenhagen General Population Study. The 25(OH)D-related genetic variants in the CYP2R1 and DCHR7 genes were genotyped in 99,012 Chinese adults and 106,911 Danish adults.
In Chinese adults, plasma 25(OH)D levels were not significantly associated with cause-specific vascular disease or mortality, with the exception of intracerebral haemorrhage (HR, 1.09 [95% CI, 1.01,1.18] per 25 nmol/L higher plasma 25(OH)D). In Europeans, plasma 25(OH)D levels were inversely associated with all types of vascular diseases and mortality. However, MR analysis did not demonstrate causal associations of genetically increased 25(OH)D levels with cause-specific vascular diseases, or mortality in both Chinese and European adults. In addition, each 25 nmol/L higher 25(OH)D was observationally associated with lower total cholesterol and low-density lipoprotein cholesterol levels, but higher high-density lipoprotein cholesterol levels. Likewise, MR analysis showed that 25(OH)D levels were not causally associated with lipids in both Chinese and European adults after Bonferroni correction.
We found no evidence to support that genetically increased 25(OH)D was associated with a lower risk of ischaemic stroke, intracerebral haemorrhage, subarachnoid haemorrhage, and lipid levels in both Chinese and European adults. These results suggest that the inverse associations of vitamin D with vascular disease could be the result of confounding.
随机对照试验和遗传分析表明,维生素 D 或 25-羟维生素 D(25[OH]D)水平可能与心血管疾病的发生没有因果关系。然而,目前尚不清楚 25(OH)D 是否与特定的血管疾病和脂质有因果关系。因此,我们在中国人群和欧洲人群中研究了 25(OH)D 与心肌梗死、卒中等特定血管疾病、缺血性心脏病、缺血性卒中等及血脂水平的因果关系。
我们采用孟德尔随机化(MR)设计,在中国科大卫比研究、哥本哈根城市心脏研究和哥本哈根普通人群研究中进行。在 99012 名中国成年人和 106911 名丹麦成年人中,检测了 CYP2R1 和 DCHR7 基因中与 25(OH)D 相关的遗传变异。
在中国成年人中,血浆 25(OH)D 水平与特定血管疾病或死亡率无显著相关性,但脑出血除外(每增加 25nmol/L 血浆 25(OH)D,HR1.09[95%CI1.01,1.18])。在欧洲人中,血浆 25(OH)D 水平与所有类型的血管疾病和死亡率呈负相关。然而,MR 分析并未显示遗传上增加的 25(OH)D 水平与中国和欧洲成年人的特定血管疾病或死亡率有因果关系。此外,每增加 25nmol/L 的 25(OH)D 与总胆固醇和低密度脂蛋白胆固醇水平降低有关,但与高密度脂蛋白胆固醇水平升高有关。同样,MR 分析显示,在经过 Bonferroni 校正后,25(OH)D 水平与中国和欧洲成年人的血脂水平没有因果关系。
我们没有证据表明遗传上增加的 25(OH)D 与中国和欧洲成年人的缺血性卒中等特定血管疾病、脑出血、蛛网膜下腔出血和血脂水平降低有关。这些结果表明,维生素 D 与血管疾病的负相关可能是混杂因素造成的。